BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 22704951)

  • 1. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population.
    Li J; Cai Y; Ke G; Xiang L; Wang L; Yang W; Wu X; Yang H
    Gynecol Oncol; 2015 May; 137(2):274-9. PubMed ID: 25759305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
    Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
    Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system.
    Baiocchi G; Silva Cestari FM; Rocha RM; Lavorato-Rocha A; Maia BM; Cestari LA; Kumagai LY; Faloppa CC; Fukazawa EM; Badiglian-Filho L; Sant'ana Rodrigues I; Soares FA
    Eur J Surg Oncol; 2013 Jul; 39(7):780-5. PubMed ID: 23518307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical versus surgical staging systems in vulvar cancer.
    Shanbour KA; Mannel RS; Morris PC; Yadack A; Walker JL
    Obstet Gynecol; 1992 Dec; 80(6):927-30. PubMed ID: 1448261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A suggested modification to FIGO stage III vulvar cancer.
    Rouzier R; Preti M; Sideri M; Paniel BJ; Jones RW
    Gynecol Oncol; 2008 Jul; 110(1):83-6. PubMed ID: 18436291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases].
    Bokhman JV; Maximov SJ; Ebert AD
    Zentralbl Gynakol; 1997; 119(4):166-72. PubMed ID: 9206922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis.
    Greene FL; Stewart AK; Norton HJ
    J Clin Oncol; 2004 May; 22(10):1778-84. PubMed ID: 14769855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival.
    Kanazawa K; Suzuki T; Tokashiki M
    Gynecol Oncol; 1999 May; 73(2):237-41. PubMed ID: 10329040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Cooke EW; Pappas L; Gaffney DK
    Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of clinical and surgical-pathologic staging of advanced vulvar cancer].
    Konefka T; Olszewski J; Makarewicz H; Emerich J
    Przegl Lek; 1999; 56(1):94-9. PubMed ID: 10375937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
    Köhler U; Schöne M; Pawlowitsch T
    Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.
    Werner HM; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; Amant F; Salvesen HB;
    Gynecol Oncol; 2012 Apr; 125(1):103-8. PubMed ID: 22100838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging and recurrence of disease in squamous cell carcinoma of the vulva.
    Ndubisi B; Kaminski PF; Olt G; Sorosky J; Singapuri K; Hackett T; Hetzel D; Zaino R; Mortel R; Podczaski E
    Gynecol Oncol; 1995 Oct; 59(1):34-7. PubMed ID: 7557612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: A comparison of the size of metastasis detected in inguinal lymph nodes.
    Robison K; Steinhoff MM; Granai CO; Brard L; Gajewski W; Moore RG
    Gynecol Oncol; 2006 Apr; 101(1):24-7. PubMed ID: 16246399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma.
    Pinto AP; Schlecht NF; Pintos J; Kaiano J; Franco EL; Crum CP; Villa LL
    Gynecol Oncol; 2004 Mar; 92(3):856-65. PubMed ID: 14984953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease.
    Farias-Eisner R; Cirisano FD; Grouse D; Leuchter RS; Karlan BY; Lagasse LD; Berek JS
    Gynecol Oncol; 1994 Apr; 53(1):55-8. PubMed ID: 8175023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.